Melanocytic Lesions: Difference between revisions

No edit summary
No edit summary
Line 323: Line 323:




'''Table 2. Rates in percentage of CNAs commonly tested on FISH panels across different melanoma subtypes.''' Values in red represent rates calculated from <25 reported cases. The number of reported cases appears in parentheses (). The symbol “-” designates data not available.
'''Table 2. Rates in percentage of copy number Aabnormalities commonly tested on FISH panels across different melanoma subtypes.*'''  
{| class="wikitable"
{| class="wikitable"
|+
|+
Line 389: Line 389:
|0 (83)
|0 (83)
|}
|}
'''Table 3. Rates of abnormalities detected by FISH panels for each melanoma subtype and 95% confidence intervals for the given rates.''' The number of cases on which the rates are based is given.
<nowiki>*</nowiki>The symbol “-” designates data not available; Values in red represent rates calculated from <25 reported cases; The number of reported cases appears in parentheses ().
 
 
'''Table 3. Rates of abnormalities detected by FISH panels for each melanoma subtype and 95% confidence intervals for the given rates.*'''
{| class="wikitable"
{| class="wikitable"
|+
|+
Line 434: Line 437:
|169
|169
|}
|}
'''Table 4. The percentage of melanomas with greater than 3 CNAs reported by CMA for each melanoma subtype and the 95% confidence lower bound for the proportion in the given number of reported cases.'''
<nowiki>*</nowiki>The number of cases on which the rates are based is given.
 
 
'''Table 4. The percentage of melanomas with greater than 3 copy number abnormalities (CNAs) reported by chromosomal microarray (CMA) for each melanoma subtype and the 95% confidence lower bound for the proportion in the given number of reported cases.'''
{| class="wikitable"
{| class="wikitable"
|+
|+